NO20031705D0 - Vaksiner - Google Patents

Vaksiner

Info

Publication number: NO20031705D0
Authority: NO; Norway
Prior art keywords: vaccinations
Prior art date: 2000-10-18

Application number

NO20031705A

Other languages

English (en)

Other versions

NO335919B1 (no

NO20031705L (no

Inventor

Nathalie Garcon

Catherine Marie Ghislai Gerard

Jean Stephenne

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-18

Filing date

2003-04-11

Publication date

2003-04-11

2000-10-18 Priority claimed from GB0025574A external-priority patent/GB0025574D0/en

2000-10-18 Priority claimed from GB0025573A external-priority patent/GB0025573D0/en

2000-10-18 Priority claimed from US09/690,921 external-priority patent/US6544518B1/en

2003-04-11 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2003-04-11 Publication of NO20031705D0 publication Critical patent/NO20031705D0/no

2003-06-14 Publication of NO20031705L publication Critical patent/NO20031705L/no

2015-03-23 Publication of NO335919B1 publication Critical patent/NO335919B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001186—MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Oncology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cell Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20031705A 2000-10-18 2003-04-11 Immunogen sammensetning, samt anvendelse derav. NO335919B1 (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0025574A GB0025574D0 (en)	2000-10-18	2000-10-18	Vaccine
GB0025573A GB0025573D0 (en)	2000-10-18	2000-10-18	Vaccine
US09/690,921 US6544518B1 (en)	1999-04-19	2000-10-18	Vaccines
PCT/EP2001/011984 WO2002032450A2 (en)	2000-10-18	2001-10-16	Vaccines

Publications (3)

Publication Number	Publication Date
NO20031705D0 true NO20031705D0 (no)	2003-04-11
NO20031705L NO20031705L (no)	2003-06-14
NO335919B1 NO335919B1 (no)	2015-03-23

Family

ID=27255945

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031705A NO335919B1 (no)	2000-10-18	2003-04-11	Immunogen sammensetning, samt anvendelse derav.

Country Status (18)

Country	Link
EP (2)	EP1326638B9 (no)
JP (1)	JP2004511527A (no)
KR (1)	KR100860893B1 (no)
CN (1)	CN100548373C (no)
AU (2)	AU2002244337B2 (no)
BR (1)	BR0114786A (no)
CA (1)	CA2425358C (no)
CZ (1)	CZ302449B6 (no)
DK (1)	DK1326638T3 (no)
ES (1)	ES2295229T3 (no)
HU (1)	HU229642B1 (no)
IL (1)	IL155282A0 (no)
MX (1)	MXPA03003408A (no)
NO (1)	NO335919B1 (no)
NZ (1)	NZ525320A (no)
PL (1)	PL208755B1 (no)
SI (1)	SI1326638T1 (no)
WO (1)	WO2002032450A2 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2257068T3 (es)	1998-08-10	2006-07-16	Antigenics Inc.	Mezclas de adyuvantes de cpg y saponinas y metodos de empleo de las mismas.
NZ513935A (en)	1999-02-17	2004-02-27	Csl Ltd	Immunogenic complexes and methods relating thereto
ES2335979T3 (es)	2001-09-14	2010-04-07	Cytos Biotechnology Ag	Empaquetamiento de cpg inmunoestimuladores en particulas similares a virus: metodo de preparacion y su uso.
CA2471092A1 (en)	2001-12-21	2003-07-10	Antigenics Inc.	Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
KR100456681B1 (ko)	2002-05-22	2004-11-10	주식회사 대웅	박테리아의 염색체 ｄｎａ 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
RU2322257C2 (ru) *	2002-06-20	2008-04-20	Цитос Байотекнолоджи Аг	КОМПОЗИЦИИ, СОДЕРЖАЩИЕ CpG-ОЛИГОНУКЛЕОТИДЫ И ВИРУСОПОДОБНЫЕ ЧАСТИЦЫ, ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ АДЪЮВАНТОВ
EP1534323A2 (en) *	2002-08-30	2005-06-01	Glaxo Group Limited	Il-14 vaccine for the treatment of asthma and atopic disorders
GEP20094767B (en)	2003-10-30	2009-09-10	Coley Pharm Group Inc	C-class oligonucleotide analogs with enhanced immunostimulatory potency
JP2008506789A (ja) *	2004-07-18	2008-03-06	シーエスエル、リミテッド	インターフェロン−ガンマ応答強化を誘発するための免疫刺激複合体及びオリゴヌクレオチド処方物
US20080267963A1 (en) *	2004-11-02	2008-10-30	Biomedical Research Model, Inc.	Methods of Cancer Treatment/Prevention Using Cancer Cell-Specific Surface Antigens
GB0504436D0 (en) *	2005-03-03	2005-04-06	Glaxosmithkline Biolog Sa	Vaccine
US11707520B2 (en)	2005-11-03	2023-07-25	Seqirus UK Limited	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
PL1945252T3 (pl)	2005-11-04	2013-11-29	Seqirus Uk Ltd	Szczepionki zawierające oczyszczone antygeny powierzchniowe otrzymane z wirusów grypy hodowanych w hodowli komórkowej i skwalen jako adiuwant
US20090181078A1 (en)	2006-09-26	2009-07-16	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
EP2484375B1 (en)	2006-09-26	2018-05-23	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
EP2370451B1 (en)	2008-12-02	2016-11-16	Wave Life Sciences Japan, Inc.	Method for the synthesis of phosphorus atom modified nucleic acids
US9278126B2 (en)	2009-02-10	2016-03-08	Seqirus UK Limited	Influenza vaccines with reduced amounts of squalene
RU2732574C2 (ru)	2009-06-05	2020-09-21	Инфекшес Дизиз Рисерч Инститьют	Синтетические глюкопиранозиллипидные адъюванты
KR101885383B1 (ko)	2009-07-06	2018-08-03	웨이브 라이프 사이언시스 리미티드	신규한 핵산 프로드러그 및 그의 사용 방법
EA030813B1 (ru)	2010-05-26	2018-10-31	Селекта Байосайенсиз, Инк	Способы генерации антительного иммунного ответа и увеличения местной индукции иммунных цитокинов при использовании синтетических наноносителей, соединенных с адъювантами
US10428019B2 (en)	2010-09-24	2019-10-01	Wave Life Sciences Ltd.	Chiral auxiliaries
MX350795B (es)	2011-04-08	2017-09-19	Inmune Design Corp	Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
EP2734208B1 (en)	2011-07-19	2017-03-01	Wave Life Sciences Ltd.	Methods for the synthesis of functionalized nucleic acids
WO2013019648A1 (en)	2011-07-29	2013-02-07	Selecta Biosciences, Inc.	Control of antibody responses to synthetic nanocarriers
WO2013033609A2 (en) *	2011-08-31	2013-03-07	Oncocyte Corporation	Methods and compositions for the treatment and diagnosis of cancer
DK2850431T3 (en)	2012-05-16	2018-07-16	Immune Design Corp	Vaccines against HSV-2
PL2872485T3 (pl)	2012-07-13	2021-05-31	Wave Life Sciences Ltd.	Asymetryczna grupa pomocnicza
CN104661664B (zh)	2012-07-13	2020-07-03	波涛生命科学有限公司	手性控制
CA2879066C (en) *	2012-07-13	2019-08-13	Shin Nippon Biomedical Laboratories, Ltd.	Chiral nucleic acid adjuvant
KR20150095668A (ko) *	2012-12-13	2015-08-21	아두로 바이오테크, 인코포레이티드	규정된 입체화학을 갖는 환식 퓨린 다이뉴클레오타이드를 포함하는 조성물, 그리고 이의 제조 방법 및 용도
EP2777711A1 (en) *	2013-03-11	2014-09-17	Icon Genetics GmbH	Her2/Neu cancer vaccine
EA032326B1 (ru)	2013-04-18	2019-05-31	Иммьюн Дизайн Корп.	Монотерапия gla для применения в лечении рака
JP2016524593A (ja)	2013-04-29	2016-08-18	メモリアルスローン−ケタリングキャンサーセンター	セカンドメッセンジャーのシグナル伝達を変えるための組成物及び方法
US9724408B2 (en)	2013-05-18	2017-08-08	Aduro Biotech, Inc.	Compositions and methods for activating stimulator of interferon gene-dependent signalling
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
CN105764525A (zh) *	2013-09-19	2016-07-13	硕腾服务有限责任公司	油基佐剂
JPWO2015108046A1 (ja)	2014-01-15	2017-03-23	株式会社新日本科学	抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
WO2015108047A1 (ja)	2014-01-15	2015-07-23	株式会社新日本科学	免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
JPWO2015108048A1 (ja)	2014-01-15	2017-03-23	株式会社新日本科学	抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
EP4137572A1 (en)	2014-01-16	2023-02-22	Wave Life Sciences Ltd.	Chiral design
EP4074336A4 (en)	2019-12-13	2024-09-04	Grand Theravac Life Science (Nanjing) Co., Ltd.	PHARMACEUTICAL COMPOSITION AND ITS USE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8205892D0 (sv) *	1982-10-18	1982-10-18	Bror Morein	Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
UA56132C2 (uk) *	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
PT1659179E (pt) *	1998-02-05	2011-09-16	Glaxosmithkline Biolog Sa	Derivados de antigénios associados a tumor da família mage e sequências de ácidos nucleicos codificando-os, utilizados para a preparação de proteínas de fusão e de composições para vacinação
DE69932717T2 (de) *	1998-05-22	2007-08-09	Ottawa Health Research Institute, Ottawa	Methoden und produkte zur induzierung mukosaler immunität
ES2257068T3 (es) *	1998-08-10	2006-07-16	Antigenics Inc.	Mezclas de adyuvantes de cpg y saponinas y metodos de empleo de las mismas.
ES2348708T3 (es) *	1999-01-29	2010-12-13	Corixa Corporation	Proteinas de fusion de her-2/neu.
CN1227030C (zh) *	1999-04-19	2005-11-16	史密丝克莱恩比彻姆生物有限公司	包含皂甙和免疫刺激寡核苷酸的佐剂组合物
WO2001051083A2 (en) *	2000-01-13	2001-07-19	Antigenics Inc.	Innate immunity-stimulating compositions of cpg and saponin and methods thereof
EP1350262B8 (en) *	2000-12-08	2008-08-13	Coley Pharmaceuticals GmbH	Cpg-like nucleic acids and methods of use thereof

2001
- 2001-10-16 PL PL365598A patent/PL208755B1/pl unknown
- 2001-10-16 NZ NZ525320A patent/NZ525320A/en not_active IP Right Cessation
- 2001-10-16 WO PCT/EP2001/011984 patent/WO2002032450A2/en not_active Ceased
- 2001-10-16 SI SI200130800T patent/SI1326638T1/sl unknown
- 2001-10-16 MX MXPA03003408A patent/MXPA03003408A/es active IP Right Grant
- 2001-10-16 JP JP2002535687A patent/JP2004511527A/ja active Pending
- 2001-10-16 CZ CZ20031093A patent/CZ302449B6/cs not_active IP Right Cessation
- 2001-10-16 AU AU2002244337A patent/AU2002244337B2/en not_active Ceased
- 2001-10-16 CA CA2425358A patent/CA2425358C/en not_active Expired - Fee Related
- 2001-10-16 EP EP01987671A patent/EP1326638B9/en not_active Expired - Lifetime
- 2001-10-16 KR KR1020077026150A patent/KR100860893B1/ko not_active Expired - Fee Related
- 2001-10-16 AU AU4433702A patent/AU4433702A/xx active Pending
- 2001-10-16 EP EP07121675A patent/EP1889630B1/en not_active Expired - Lifetime
- 2001-10-16 ES ES01987671T patent/ES2295229T3/es not_active Expired - Lifetime
- 2001-10-16 BR BR0114786-2A patent/BR0114786A/pt not_active IP Right Cessation
- 2001-10-16 HU HU0402067A patent/HU229642B1/hu not_active IP Right Cessation
- 2001-10-16 DK DK01987671T patent/DK1326638T3/da active
- 2001-10-16 IL IL15528201A patent/IL155282A0/xx unknown
- 2001-10-16 CN CNB018206611A patent/CN100548373C/zh not_active Expired - Fee Related
2003
- 2003-04-11 NO NO20031705A patent/NO335919B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2425358A1 (en)	2002-04-25
EP1889630B1 (en)	2011-11-23
NO335919B1 (no)	2015-03-23
PL208755B1 (pl)	2011-06-30
MXPA03003408A (es)	2005-06-30
AU4433702A (en)	2002-04-29
EP1889630A1 (en)	2008-02-20
CZ20031093A3 (cs)	2003-08-13
EP1326638B9 (en)	2008-02-20
NZ525320A (en)	2004-10-29
CN100548373C (zh)	2009-10-14
HUP0402067A3 (en)	2012-09-28
BR0114786A (pt)	2003-08-12
PL365598A1 (en)	2005-01-10
KR20070114230A (ko)	2007-11-29
EP1326638A2 (en)	2003-07-16
ES2295229T3 (es)	2008-04-16
EP1326638B1 (en)	2007-11-28
WO2002032450A2 (en)	2002-04-25
CN1481255A (zh)	2004-03-10
CZ302449B6 (cs)	2011-05-25
KR100860893B1 (ko)	2008-09-29
CA2425358C (en)	2012-08-21
DK1326638T3 (da)	2008-03-25
WO2002032450A3 (en)	2002-10-10
JP2004511527A (ja)	2004-04-15
IL155282A0 (en)	2003-11-23
NO20031705L (no)	2003-06-14
HU229642B1 (en)	2014-03-28
SI1326638T1 (sl)	2008-04-30
AU2002244337B2 (en)	2005-08-11
HUP0402067A2 (hu)	2005-01-28

Publication	Publication Date	Title
NO20030823L (no)	2003-04-23	Vaksiner
NO20031705D0 (no)	2003-04-11	Vaksiner
NO20031483D0 (no)	2003-04-01	Vaksine
NO20021433D0 (no)	2002-03-21	Vaksiner
NO20024172L (no)	2002-11-01	Vaksine
ATE290000T1 (de)	2005-03-15	Muscarinagonisten
ATE252099T1 (de)	2003-11-15	Biarylcarboxamide
DE10136334B8 (de)	2009-11-26	Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de)	2005-12-15	Thiazinoxazolidinon
ATA2932001A (de)	2004-11-15	Schneefräse
ATE262530T1 (de)	2004-04-15	Indolochinazolinone
ATE298751T1 (de)	2005-07-15	7-oxopyridoryrimidine
DE10192638T1 (de)	2002-10-31	Bohrstangenladevorrichtung
AR028336A1 (es)	2003-05-07	4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de)	2011-05-15	Sulfonylguanidine
DE10196064T1 (de)	2003-03-13	Halbleiterfotodektionsgerät
NO20024322L (no)	2002-09-10	Sekvens
AR027931A1 (es)	2003-04-16	Antitranspirantes
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
DE50007634D1 (de)	2004-10-07	Kardioplegieballonkatheter
DE10052925B4 (de)	2005-03-10	Schaukelbett
ATE476423T1 (de)	2010-08-15	Benzoylpyridazine
DE10195909T1 (de)	2003-02-20	Viehfüttervorrichtung
DE10085445T1 (de)	2003-02-27	Drahterodierbearbeitungseinrichtung
AR027982A1 (es)	2003-04-23	Aril- y heteroarilsulfonatos

Legal Events

Date	Code	Title	Description
2017-05-29	MM1K	Lapsed by not paying the annual fees